万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.lww.com/headtraumarehab/pages/default.aspx
3、投稿网址：
https://www.editorialmanager.com/jhtr/default.aspx
4、官网邮箱：corrigan.1@osu.edu（主编）
5、期刊刊期：双月刊，一年出版六期。
2021年2月25日星期四
投稿须知【官网信息】
Instructions for Authors
SCOPE
The Journal of Head Trauma Rehabilitation (JHTR) is a bimonthly journal devoted to presenting scientific information on restoring function and limiting disability due to traumatic brain injury (TBI). The primary aim of JHTR is to disseminate original research to professionals from multiple disciplines who study and/or treat persons who have experienced a TBI. All published research manuscripts receive masked peer review.
Articles appearing in JHTR address functional effects of TBI and interventions intended to ameliorate those effects. Findings should inform the treatment of individuals and families affected by TBI, the systems of care in which services are provided, or the epidemiologic and public health issues relevant to TBI. Manuscripts are expected to address questions that would be of interest to the wide range of professionals involved in TBI care--articles that are narrowly focused or relevant to only a single discipline typically are not published.
Populations of interest. Research reported in JHTR is generally limited to human subjects with a history of TBI, the families and caregivers of individuals with TBI, and/or the systems of care in which TBI services and research are undertaken. Studies may address injuries of any severity, sustained by any age group. If a study's sample includes individuals with acquired brain injuries other than TBI, analyses must be included to confirm that the findings reported for the entire sample are specifically true for those with a history of TBI.
Case ascertainment. Procedures used to determine that participants incurred a TBI must employ proven clinical techniques or validated research methods of TBI identification.
Transparency and openness. Please state in the article whether data, programming code or other materials are available to other researchers and, if so, how to access them. Data or code that was not the authors' own should be cited in the text and listed in the reference section.
Randomized controlled trials must be preregistered on clinicaltrials.gov or similar independent, institutional registry, prior to the initiation of data collection. Preregistration, including of pre-analysis plans, is recommended for all study designs. If a trial is preregistered, a link to the registry should be provided in the main text.
Inclusion of diverse participants. Please provide sex or gender-specific and racial/ethnic-specific data in describing the outcomes of experimental and observational analyses, or specifically state that no sex-based or racial/ethnic-based differences were present. Where applicable, authors should explain why people of a particular age, race, ethnicity, gender or sex were excluded from a study.
The term "sex" should be used as a classification, generally as male or female, according to the reproductive organs and functions that derive from the chromosomal complement. In the study of human subjects, the term "gender" should be used to refer to a person's self-representation as male or female, or how that person is responded to by social institutions on the basis of the individual's gender presentation.
MANUSCRIPT SUBMISSION
Article types: Original articles may employ experimental, observational or qualitative designs. JHTR will publish replication studies. Systematic reviews, scoping reviews and meta-analyses are also of interest.
Commentaries and Letters to the Editor will be reviewed and accepted at the discretion of the Editors. Other special communications must be discussed with the Editor-in-Chief prior to submission.
Investigations of the efficacy of interventions using only quasi-experimental designs typically are not accepted. Case studies or case series will not be reviewed unless they address a seminal clinical condition or procedure that has not been previously reported in the published literature.
Authors are strongly encouraged to consult relevant guidelines for research reporting found at <www.equator-network.org>. Authors have the option of uploading a completed checklist with page and line numbers indicated for each criterion met.
Unless an author has been invited by an issue editor to submit a manuscript for a topical issue, all original research should be submitted as "Unsolicited (Focus on Clinical Research)".
Article length: Manuscripts should not exceed 3500 words excluding abstract, references, tables, and figure legends. The total number of tables and figures should not exceed five (5). Typically, except for review articles, the number of references should not exceed 50. Authors are encouraged to use Supplemental Digital Content (SDC) for manuscript details that enhance but are not central to the comprehension of the paper. SDC is linked to the article indefinitely via the JHTR website (for more information, see description below).
JHTR will accept Research Letters that do not exceed 2000 words, three (3) tables and/or figures and 15 references. This vehicle may be used for timely and innovative communication of empirical findings. Submit a Research Letter as "Original Research" and "Unsolicited". The title should begin "Research Letter:..." to alert the Editors and readers to the intended type of communication.
Authorship: JHTR follows the International Committee of Medical Journal Editors recommendations for the roles of authors and contributors. Manuscripts should be limited to eight (8) authors. More than eight (8) authors requires submission of additional documentation of roles and contributions.
Online manuscript submission: All manuscripts must be submitted online through the Web site at www.edmgr.com/jhtr, which can also be accessed through the journal’s Web page.
First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to reregister, even if your status changes (ie, author, reviewer, or editor).
Authors: Please click the Log-in button from the menu at the top of the page and log-in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact John D. Corrigan, PhD, Editor-in-Chief at corrigan.1@osu.edu.
CONFLICTS OF INTEREST
Authors must state all possible conflicts of interest in the Title Page of the manuscript, including financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:
Conflicts of Interest and Source of Funding: Author A has received honoraria from Company Z. Author B is currently receiving a grant (#12345) from Organization Y and is on the speaker’s bureau for Organization X—the CME organizers for Company A. For the remaining authors none were declared.
In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).
A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.
LWW AUTHOR’S MANUSCRIPT CHECKLIST FOR JOURNALS
Authors should pay particular attention to the following items before submitting their manuscripts:
Manuscript Preparation
JHTR uses the American Medical Association Manual of Style, 10th edition.
JHTR requires authors to use person-first language—avoid phrasing such as “the brain-injured participant”or the “TBI patient”and replace with “participant with a brain injury” or “patient with a TBI.”
MANUSCRIPTS SHOULD BE LINE NUMBERED IN THEIR ORIGINAL FORMAT (e.g., Microsoft Word line numbering).
Manuscripts should be double-spaced, including quotations, lists, references, footnotes, figure captions, and all parts of tables.
Manuscripts should be ordered as follows: title page, abstracts, text, references, appendices, tables, and any illustrations.
Do not embed tables or figures in the text but provide guidance in the text where a table or figure should be placed (e.g., Table X about here").
TO MAINTAIN A MASKED REVIEW PROCESS, IT IS THE AUTHOR'S RESPONSIBILITY TO MAKE EVERY ATTEMPT TO MASK ALL INFORMATION IN THE MANUSCRIPT THAT WOULD REVEAL THE IDENTITY OF THE AUTHOR TO THE REVIEWER. THIS VERSION OF THE MANUSCRIPT IS REFERRED TO AS THE "MASKED" MANUSCRIPT WHEN UPLOADING DOCUMENTS. Both a masked and unmasked version of the main text will need to be uploaded during manuscript submission.
An accompanying cover letter should include attestations that (1) the work is original and has not been published or under review elsewhere; (2) all authors contributed to the work; and (3) the research was conducted consistent with ethical guidelines for the conduct of research.
The cover letter should also summarize any conflicts of interest affecting any authors.
Title page including (1) title of the article; (2) author names (with highest academic degrees) and affiliations (including titles, departments, and name and location of institutions of primary employment); (3) all possible conflicts of interest including financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest; (4) disclosure of funding received for this work including from any of the following organizations with public or open access policies: National Institutes of Health (NIH), National Institute on Disability Independent Living and Rehabilitation Research, Veterans Administration, Wellcome Trust, and the Howard Hughes Medical Institute; and (5) any acknowledgments, credits, or disclaimers.
A structured abstract of no more than 300 words should be prepared (see "how to compose a structured abstract for JHTR"). Authors should use telegraphic language where possible, including omission of introductory clauses. Headings should typically include the following: Objective, Setting, Participants, Design, Main Measures, Results, and Conclusion. The Conclusion section should encapsulate the clinical implications of the results, not merely restate the findings.
Include up to 10 key words that describe the contents of the article such as those that appear in the Cumulative Index to Nursing and Allied Health Literature (CINAHL) or the National Library of Medicine’s (NLM’s) Medical Subject Headings (MeSH).
There should be a clear indication of the placement of all tables and figures in text.
The author is responsible for obtaining written permission for any borrowed text, tables, or figures.
Include at the beginning of the Methods section a statement describing approval by the appropriated institution's review board for human participants' protection or the basis for waiver of such approval.
Abstract
Objective
State primary objective or hypothesis
Setting
Where the data were collected (e.g., inpatient, outpatient, survey)
Participants
Key eligibility Criteria
Number enrolled in study (by group if group comparison study)
Number analyzed (by group if appropriate)
Design
Type of design (for example, randomized, quasi-randomized, noninferiority, observational, prospective or retrospective)
Brief description of intervention (for each group, if the design involved groups receiving different interventions or control conditions)
Describe whether or not participants, intervention providers, and those assessing the outcomes were blinded
If randomized or quasi-randomized, describe method of group allocation
Main Measures
Clearly identify primary outcome measure
List secondary outcome measures as such and word limit allows
Results
Result for primary outcome measure (by group if groups were compared) and the estimated effect size and its precision
Significant adverse events
Conclusion.
Encapsulate the clinical implications of the results; do not merely restate the findings.
NOTE: CONCLUSIONS MUST BE SUPPORTED BY RESULTS
References
References must be cited in text and styled in the reference list according to the American Medical Association Manual of Style, 10th edition, copyright 2007 American Medical Association. They must be numbered consecutively in the order they are cited and listed in that sequence (not alphabetically); reference numbers may be used more than once throughout an article. Page numbers should appear with the text citation following a specific quote. References should be double-spaced and placed at the end of the text.
References
References must be cited in text and styled in the reference list according to the American Medical Association Manual of Style, 10th edition, copyright 2007 American Medical Association. They must be numbered consecutively in the order they are cited and listed in that sequence (not alphabetically); reference numbers may be used more than once throughout an article. Page numbers should appear with the text citation following a specific quote. References should be double-spaced and placed at the end of the text.
References should not be created using Microsoft Word’s automatic footnote/endnote feature.
Figures
A. Four Steps for Submitting Artwork
Learn about Digital Art creation here.
Create, Scan, and Save your artwork according to the Digital Artwork Guideline Checklist.
Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
B. Color Figures: The journal accepts color figures for publication that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction in print. If they decide not to pay for color reproduction in print, they can request that the figures be converted to black and white at no charge. All color figures can appear in color in the online version of the journal at no charge. (Note: this includes the online version on the journal website and Ovid, but not the iPad edition currently.)
C. Digital Artwork Guideline Checklist Basics to have in place before submitting your digital art.
Artwork saved as JPG, TIFF and EPS files. Do not save TIFFs as compressed files.
Artwork created as the actual size (or slightly larger) than it will appear in the journal. (To get an idea of the size images should be when they print, study a copy of the journal. Measure the artwork typically shown and scale your image to match.)
Crop out any white or black space surrounding the image.
Text and fonts in any figure are one of the acceptable fonts: Helvetica, Times Roman, Symbol, Mathematical PI, and European PI.
Color images are created/scanned and saved and submitted as CMYK only. Do not submit any figures in RGB mode because RGB is the color mode used for screens/monitors and CMYK is the color mode used for print.
Line art saved at a resolution of at least 1200 dpi.
Images saved at a resolution of at least 300 dpi.
Each figure saved as a separate file and saved separately from the accompanying text file.
For multipanel or composite figures only: Any figure with multiple parts should be sent as one file, with each part labeled the way it is to appear in print.
Remember:
Artwork generated from office suite programs such as CorelDRAW, MS Word, Excel, and artwork downloaded from the Internet (JPEG or GIF files) cannot be used because the quality is poor when printed.
Cite figures consecutively in your manuscript.
Number figures in the figure legend in the order in which they are discussed.
Upload figures consecutively to the Editorial Manager Web site and number figures consecutively in the Description box during upload.
All electronic art that cannot be successfully uploaded must be submitted on a 31/2-inch high-density disk, a CD-ROM, or an Iomega Zip disk, accompanied by high-resolution laser prints of each image.
Tables Tables should be on a separate page at the end of the manuscript. Number tables consecutively and supply a brief title for each. Include explanatory footnotes for all nonstandard abbreviations. Cite each table in the text in consecutive order. If you use data from another published or unpublished source, obtain permission and acknowledge fully.
Supplemental Digital Content Authors may submit SDC that enhances their article’s text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copyedited by LWW staff; they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit the Checklist for Supplemental Digital Content.
SDC Call-outs: SDC must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as “Supplemental Digital Content,” include the sequential list number and provide a description of the supplemental content. All descriptive text should be included in the call-out, as it will not appear elsewhere in the article.
Example:
We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.
List of Supplemental Digital Content: A listing of SDC items must be submitted at the end of the manuscript file. Include the SDC number and file type. This text will be removed by our production staff and not be published.
Example:
Supplemental Digital Content 1. wmv
SDC File Requirements: All acceptable file types are permissible up to 10 MB. For audio or video files greater than 10 MB, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit the Checklist for Supplemental Digital Content.
Permissions
Authors are responsible for obtaining signed letters from copyright holders granting permission to reprint material being borrowed or adapted from other sources, including previously published material of your own. Authors must obtain written permission for material that has not been created and submitted to LWW for a specific publication (including forms, checklists, cartoons, text, tables, figures, exhibits, glossaries, and pamphlets); concepts, theories, or formulas used exclusively in a chapter or section; direct quotes from a book or journal that are more than 30% of a printed page; and all excerpts from newspapers or other short articles. Without written permission from the copyright holder, these items may not be used. Where permission has been granted, the author should follow any special wording stipulated by the granter when attributing the source in the manuscript. Letters of permission must be submitted before publication of the manuscript.
Open access
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Open Health Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php
FAQ for open access
http://www.wkopenhealth.com/openaccessfaq.php
